Search Within

Sergio Andres Giralt

Formats
  1. Meeting Abstract (642)
  2. Journal Article (374)
  3. Research Letter (19)
  4. Review (15)
  5. Guidelines (5)
  6. Editorial (4)
  7. Book Section (3)
  8. Correspondence (3)
Groups
  1. Bone Marrow Transplant (1065)
  2. Center for Hematologic Malignancies (1065)
  3. Department of Medicine (1065)
  4. Hematologic Malignancies, Division of (1065)
  5. Survivorship Research (699)
  6. CTCR Scholars (553)

More Groups

People
  1. Miguel-Angel Perales (428)
  2. Sean Devlin (379)
  3. Gunjan Shah (308)
  4. Michael Scordo (276)
  5. Heather Landau (260)
  6. Ann Jakubowski (241)

More People

Years
  1. 2025 (14)
  2. 2024 (65)
  3. 2023 (104)
  4. 2022 (77)
  5. 2021 (66)
  6. 2020 (91)

More Years

Publications
  1. Blood (314)
  2. Biology of Blood and Marrow Transplantation (275)
  3. Bone Marrow Transplantation (80)
  4. Clinical Lymphoma, Myeloma and Leukemia (60)
  5. Journal of Clinical Oncology (40)
  6. Transplantation and Cellular Therapy (36)

More Publications

Publishers
  1. Elsevier Inc. (384)
  2. American Society of Hematology (348)
  3. Nature Publishing Group (109)
  4. American Society of Clinical Oncology (42)
  5. Taylor & Francis Group (35)
  6. Ferrata Storti Foundation (13)

More Publishers

Results (1065)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Double-unit cord blood (CB) transplantation with haplo-identical CD34+ cells (haplo-dCBT) may speed neutrophil recovery although successful bridging is contingent on close haplo-winning CB unit HLA-match
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Mazis, C.; Maloy, M.; Naputo, K.; Afuye, A. O.; Bhatt, V.; Scaradavou, A.; O'Reilly, R. J.; Avecilla, S. T.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Multicenter microbiota analysis indicates that pre-HCT microbiota injury is prevalent across geography and predicts poor overall survival
    Meeting Abstract

    Peled, J. U.; Gomes, A. L. C.; Stein-Thoeringer, C. K.; Slingerland, J. B.; Slingerland, A. E.; Weber, D.; Markey, K. A.; Smith, M.; Ponce, D.; Clurman, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Maintenance with 5-azacytidine for acute myeloid leukemia and myelodysplastic syndrome patients
    Meeting Abstract

    Oran, B.; de Lima, M.; Garcia-Manero, G.; Thall, P. F.; Lin, R. T.; Alousi, A. M.; Hosing, C.; Kebriaei, P.; Popat, U.; Giralt, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Pre-transplant and peri-d100 gastrointestinal dysbiosis is associated with the subsequent development of chronic graft-versus-host disease
    Meeting Abstract

    Markey, K. A.; Gomes, A. L. C.; Littmann, E. R.; Devlin, S. M.; Slingerland, A. E.; Slingerland, J. B.; Clurman, A.; Moore, G.; Fatmi, S. A.; Maloy, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • A simple geriatric vulnerability index for older patients undergoing allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Jakubowski, A. A.; Shahrokni, A.; Dahi, P. B.; Perales, M. A.; Tamari, R.; Shaffer, B. C.; Sauter, C. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Homebound autologous hematopoietic cell transplantation for plasma cell disorders in an urban setting is safe for patients and preferred by patients and caregivers
    Meeting Abstract

    Landau, H. J.; Shah, G. L.; Reeds, M.; Hilden, P.; Andrejko, M.; Applebaum, A.; Batalha, J.; Cazeau, N.; Chung, D. J.; Cortes, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mastey, D.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Tavitian, E.; Salcedo, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Loss of microbiota diversity after autologous stem cell transplant is comparable to injury in allogeneic stem cell transplant
    Meeting Abstract

    Khan, N.; Peled, J. U.; Gomes, A. L. C.; Devlin, S. M.; Rondon-Clavo, C.; Clurman, A.; Slingerland, J. B.; Slingerland, A. E.; Maloy, M.; Sung, A. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save